Universal Corporation Receives NYSE Notice Regarding Filing of Form 10-Q for the Fiscal Quarter Ended September 30, 2024
Universal (NYSE:UVV) received a notice from NYSE on November 19, 2024, regarding non-compliance with listing standards due to delayed filing of its Q2 FY2025 Form 10-Q. The delay stems from an ongoing internal investigation. While the notice doesn't immediately affect UVV's NYSE listing, the company has six months until May 18, 2025, to file the Form 10-Q and regain compliance. NYSE may grant an additional six-month extension or initiate delisting proceedings at its discretion. Universal expects to file within the initial six-month period but cannot guarantee this timeline.
Universal (NYSE:UVV) ha ricevuto una comunicazione dalla NYSE il 19 novembre 2024, riguardante la non conformità agli standard di quotazione a causa del ritardo nella presentazione del suo modulo 10-Q per il secondo trimestre dell'anno fiscale 2025. Il ritardo è dovuto a un'indagine interna in corso. Anche se la comunicazione non influisce immediatamente sulla quotazione di UVV in NYSE, l'azienda ha sei mesi, fino al 18 maggio 2025, per presentare il modulo 10-Q e ripristinare la conformità. La NYSE può concedere un'ulteriore estensione di sei mesi o avviare le procedure di delisting a sua discrezione. Universal prevede di presentare la documentazione entro il primo periodo di sei mesi, ma non può garantire questa tempistica.
Universal (NYSE:UVV) recibió un aviso de la NYSE el 19 de noviembre de 2024, sobre el incumplimiento de los estándares de cotización debido al retraso en la presentación de su Formulario 10-Q del segundo trimestre del año fiscal 2025. El retraso se debe a una investigación interna en curso. Si bien el aviso no afecta de inmediato la cotización de UVV en la NYSE, la compañía tiene seis meses, hasta el 18 de mayo de 2025, para presentar el Formulario 10-Q y restablecer el cumplimiento. La NYSE puede conceder una extensión adicional de seis meses o iniciar procedimientos de exclusión a su discreción. Universal espera presentar dentro del período inicial de seis meses, pero no puede garantizar este cronograma.
유니버설 (NYSE:UVV)는 2024년 11월 19일 NYSE로부터 2025 회계연도 2분기 10-Q 양식 제출 지연으로 인한 상장 기준 미준수에 대한 통지를 받았습니다. 이 지연은 현재 진행 중인 내부 조사로 인해 발생했습니다. 이 통지는 UVV의 NYSE 상장에 즉각적인 영향을 미치지 않지만, 회사는 2025년 5월 18일까지 10-Q 양식을 제출하고 준수를 회복하기 위해 6개월의 시간이 주어집니다. NYSE는 자의적으로 추가 6개월의 연장을 허가하거나 상장 폐지 절차를 시작할 수 있습니다. 유니버설은 초기 6개월 기간 내에 제출할 것으로 예상하고 있지만 이 일정은 보장할 수 없습니다.
Universal (NYSE:UVV) a reçu un avis de la NYSE le 19 novembre 2024 concernant le non-respect des critères d'inscription en raison du retard dans le dépôt de son formulaire 10-Q pour le deuxième trimestre de l'exercice fiscal 2025. Ce retard est dû à une enquête interne en cours. Bien que l'avis n'affecte pas immédiatement le classement de UVV à la NYSE, la société a six mois, jusqu'au 18 mai 2025, pour déposer le formulaire 10-Q et retrouver sa conformité. La NYSE peut accorder une prolongation de six mois supplémentaire ou initier des procédures de radiation à sa discrétion. Universal s'attend à déposer dans le premier délai de six mois, mais ne peut garantir ce calendrier.
Universal (NYSE:UVV) erhielt am 19. November 2024 eine Mitteilung von der NYSE über die Nichteinhaltung der Listing-Standards aufgrund der verspäteten Einreichung seines Formulars 10-Q für das zweite Quartal des Geschäftsjahres 2025. Die Verzögerung resultiert aus einer laufenden internen Untersuchung. Während die Mitteilung UVVs NYSE-Listing nicht sofort beeinflusst, hat das Unternehmen bis zum 18. Mai 2025, also sechs Monate Zeit, um das Formular 10-Q einzureichen und die Konformität wiederherzustellen. Die NYSE kann nach eigenem Ermessen eine zusätzliche sechsmonatige Fristverlängerung gewähren oder ein Delisting-Verfahren einleiten. Universal erwartet, innerhalb des ersten sechsmonatigen Zeitraums einzureichen, kann jedoch diesen Zeitrahmen nicht garantieren.
- None.
- Failure to file Q2 FY2025 Form 10-Q on time
- Non-compliance with NYSE listing standards
- Ongoing internal investigation delaying financial reporting
- Risk of potential NYSE delisting if compliance isn't achieved
- Uncertainty regarding timeline for Form 10-Q filing completion
Insights
This NYSE compliance notice raises significant red flags. The delayed 10-Q filing due to an ongoing internal investigation is concerning, particularly since the nature and scope of the investigation remain undisclosed. Such delays often indicate potential accounting irregularities, internal control issues, or other material concerns that could impact financial statements.
The 6-month compliance window provides some breathing room, but the lack of specificity about the investigation's timeline and scope creates uncertainty. While delisting risk appears low in the immediate term, the situation warrants close monitoring. Historical patterns show that companies facing similar circumstances often experience increased volatility and declining investor confidence until resolution.
The timing is particularly problematic as it affects Q2 FY2025 financial statements, a important period for assessing the company's performance. Investors should exercise caution and watch for additional disclosures about the investigation's nature and potential financial impact.
The NYSE Notice has no immediate effect on the listing of the Company's common stock on the NYSE. The NYSE Notice informed the Company that, under NYSE rules, the Company has six months from November 18, 2024, to regain compliance with the NYSE listing standards by filing the Form 10-Q with the SEC. If the Company fails to file the Form 10-Q within the six-month period, the NYSE may grant, in its sole discretion, an extension of up to six additional months for the Company to regain compliance, depending on the specific circumstances. The NYSE Notice also noted that the NYSE may nevertheless, in its own discretion, commence delisting proceedings at any time during such period.
As previously disclosed in the Company's Notification of Late Filing on Form 12b-25, filed on November 12, 2024 (the "Form 12b-25") with the SEC, the Company was unable to file the Form 10-Q on a timely basis due to an ongoing internal investigation. As a result of the additional time required to complete its internal investigation, the process of finalizing financial statements for the second quarter of fiscal year 2025 could not be completed on a timely basis.
The Company is committed to completing a deliberate, thorough investigation while diligently working to fulfill all reporting obligations and currently expects to file the Form 10-Q within the six-month period granted by the NYSE Notice; however, there can be no assurance that the Form 10-Q will be filed within such period.
About Universal Corporation
Universal Corporation (NYSE: UVV) is a global agricultural company with over 100 years of experience supplying products and innovative solutions to meet our customers' evolving needs and precise specifications. Through our diverse network of farmers and partners across more than 30 countries on five continents, we are a trusted provider of high-quality, traceable products. We leverage our extensive supply chain expertise, global reach, integrated processing capabilities, and commitment to sustainability to provide a range of products and services designed to drive efficiency and deliver value to our customers. For more information, visit www.universalcorp.com.
CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING INFORMATION
This release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Among other things, these statements include statements regarding expectations about the Company's filing of its Form 10-Q for the quarter ended September 30, 2024. These forward-looking statements are generally identified by the use of words such as we "expect," "believe," "anticipate," "could," "should," "may," "plan," "will," "predict," "estimate," and similar expressions or words of similar import. These forward-looking statements are based upon management's current knowledge and assumptions about future events and involve risks and uncertainties that could cause actual results, performance, or achievements to be materially different from any anticipated results, prospects, performance, or achievements expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, the uncertainty of the ultimate findings of the ongoing internal investigation, as well as the timing of its completion and costs and expenses arising out of the ongoing internal investigation process and its results; the impact of the ongoing internal investigation on us, our management and operations, including financial impact as well as any litigation or regulatory action that may arise from the ongoing internal investigation; the impact of the internal investigation on our conclusions regarding the effectiveness of our internal control over financial reporting and our disclosure controls and procedures; our ability to regain compliance with NYSE listing requirements; success in pursuing strategic investments or acquisitions and integration of new businesses and the impact of these new businesses on future results; product purchased not meeting quality and quantity requirements; our reliance on a few large customers; our ability to maintain effective information technology systems and safeguard confidential information; anticipated levels of demand for and supply of our products and services; costs incurred in providing these products and services including increased transportation costs and delays attributed to global supply chain challenges; timing of shipments to customers; higher inflation rates; changes in market structure; government regulation and other stakeholder expectations; economic and political conditions in the countries in which we and our customers operate, including the ongoing impacts from international conflicts; product taxation; industry consolidation and evolution; changes in exchange rates and interest rates; impacts of regulation and litigation on its customers; industry-specific risks related to its plant-based ingredient businesses; exposure to certain regulatory and financial risks related to climate change; changes in estimates and assumptions underlying our critical accounting policies; the promulgation and adoption of new accounting standards, new government regulations and interpretation of existing standards and regulations; and general economic, political, market, and weather conditions. Actual results, therefore, could vary from those expected. Please also refer to such other factors as discussed in Part I, Item 1A. "Risk Factors" of Universal's Annual Report on Form 10-K for the fiscal year ended March 31, 2024, and related disclosures in other filings which have been filed with the
View original content to download multimedia:https://www.prnewswire.com/news-releases/universal-corporation-receives-nyse-notice-regarding-filing-of-form-10-q-for-the-fiscal-quarter-ended-september-30-2024-302314579.html
SOURCE Universal Corporation
FAQ
Why did Universal (UVV) receive a NYSE notice on November 19, 2024?
What is the deadline for Universal (UVV) to regain NYSE compliance?
What is causing the delay in Universal 's (UVV) Q2 FY2025 10-Q filing?